Fact CheckerSign in

NCT01464216Active, not recruiting

MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness

Source: ClinicalTrials.gov · Last updated 21 Jun 2022

Brief summary (registry, in English)

The purpose of the study is to combine and correlate data from morphological and functional MRI, molecular signatures of tumor hypoxia, the presence of micrometastases and tumor hypoxia with the goal being predicting of prostate cancer aggressiveness.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
120 (actual)
First submitted
31 Oct 2011
Start date
1 Oct 2011
Primary completion date
31 Dec 2022
Lead sponsor
Oslo University Hospital
NCT number
NCT01464216

What you commit to

  • Study type: Observational
  • Participants enrolled: 120
  • From 1 Oct 2011 to the primary completion date, 31 Dec 2022
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients previously undergone pelvic surgery or radiation therapy

Other

  • Patient with contraindication to MR or MR contrast media according to clinical practice.
  • Patients who want to withdraw for any reason during the study.

Who the study is looking for

  • Patients suitable for surgery with confirmed prostate cancer, Gleason grade ≥ 3
  • Patient has received no prior treatment for prostate cancer.
  • Patient has adequate renal function: Estimated creatinine clearance ≥ 60 ml/minute.
  • Patient must sign written informed consent according to the protocol approved by the Regional Ethics Committee.

Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Oslo University Hospital
Coordinator of this site? Confirm its status
OsloNorwayUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.